NFC
ABMD

Northeast Financial Consultants’s Abiomed Inc ABMD Stock Holding History

Northeast Financial Consultants’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,812
Closed -$445K – 359
2022
Q3 		$445K Hold
1,812
– – 0.03% 206
2022
Q2 		$448K Hold
1,812
– – 0.03% 205
2022
Q1 		$600K Hold
1,812
– – 0.03% 206
2021
Q4 		$651K Hold
1,812
– – 0.04% 193
2021
Q3 		$590K Hold
1,812
– – 0.04% 205
2021
Q2 		$566K Hold
1,812
– – 0.04% 209
2021
Q1 		$578K Hold
1,812
– – 0.04% 194
2020
Q4 		$587K Sell
1,812
-188
-9% -$52K 0.05% 179
2020
Q3 		$554K Hold
2,000
– – 0.05% 168
2020
Q2 		$483K Hold
2,000
– – 0.05% 174
2020
Q1 		$290K Hold
2,000
– – 0.03% 203
2019
Q4 		$341K Hold
2,000
– – 0.03% 220
2019
Q3 		$356K Hold
2,000
– – 0.04% 210
2019
Q2 		$521K Hold
2,000
– – 0.05% 181
2019
Q1 		$571K Buy
+2,000
New +$665K 0.06% 169

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Northeast Financial Consultants's ABMD Position: Q4 2022 in Review

Northeast Financial Consultants sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,812 shares — an estimated $445K sold.

Northeast Financial Consultants first reported a position in ABMD in Q1 2019 and held it in 15 quarters. The position peaked at $651K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Northeast Financial Consultants reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Northeast Financial Consultants sold 1,812 Abiomed Inc shares in Q4 2022, an estimated $445K.
  • Northeast Financial Consultants first reported a position in Abiomed Inc in Q1 2019 and held it in 15 quarters.
  • Northeast Financial Consultants's Abiomed Inc position peaked at $651K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Northeast Financial Consultants's 13F filing for Q4 2022, filed 13 Feb 2023.